Latest FDA Stories
The Firm is representing numerous plaintiffs who have filed similar Risperdal gynecomastia claims in the mass tort proceeding underway in Pennsylvania. New York,
Approval represents fourth indication for IMBRUVICA in the U.S. HORSHAM, Pa., Jan. 29, 2015 /PRNewswire/ -- Janssen Biotech, Inc. ("Janssen") today announced that the U.S.
- First and Only FDA-Approved Treatment for WM Patients SUNNYVALE, Calif., Jan. 29, 2015 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC) today announced that the U.S.
CorMedix is Developing Neutrolin for the Prevention of Catheter Related Bloodstream Infections and Maintenance of Catheter Patency in Hemodialysis, Oncology and Intensive Care BRIDGEWATER,
Restylane® Silk provides natural-looking lip definition and smooths wrinkles around the mouth FORT WORTH, Texas, Jan.
Only Smart Phone Based ECG Device that Can Provide Multiple Types of ECG Analysis SAN FRANCISCO, Jan.
CASTLE ROCK, Colo., Jan.
Skin expert and founder of the award-winning skin clinic FACE Skincare~Medical~Wellness, Holly CaSaroll introduces Bellafill®, an injectable collagen filler that naturally corrects acne scars
Xarelto Drug Safety Label Warns Bleeding Is A Common Adverse Reaction Of The Blood Thinner And Xarelto Bleeding Side-Effects Lawsuits Claim The Anticoagulant Does Not Have An Antidote Should Severe